Pub Date : 2025-12-01Epub Date: 2025-03-13DOI: 10.1007/s13193-025-02276-x
Alaa Abdulqader Abdulrazaq, Duraid Taha Abdulkareem
Benign prostatic hyperplasia (BPH) and prostatic cancer both represent prostate lesions affecting males. These conditions occur due to the presence of inflammation within the prostate gland. This inflammatory process causes tissue injury and cellular modifications, which are primarily through the cytokine synthesis and secretion. Distinctly, IL-6 (interleukin 6) emerges as a vital part in prostate disease, exerting a profound influence on its development. In addition, the anti-inflammatory cytokines' inclusion, such as tumor necrosis factor beta-1 (TGFβ-1), is evident in the development of both benign prostatic hyperplasia and prostatic cancer. In recent discoveries, researchers are more focused on complex interaction between IL-6 and TGFβ-1 in the prostate pathophysiology. The article aims to assess the IL-6 and TGFβ-1 immunohistochemical expression in prostatic benign and malignant lesions. Formalin-fixed samples that were encapsulated in paraffin were utilized in this work. They were collected from the department of histopathology et al.-Ramadi-Teaching Hospital from patients who were diagnosed with hyperplasia and carcinoma of the prostate. To detect the expression of TGFβ-1 and IL-6, immunohistochemical analysis was performed on the tissue sections. The intensity of stromal staining was determined to assess the stromal expression. Concerning prostate cancer, the relationship between cytokine expression and the Gleason index score was discussed in this work. The results confirm that the TGFβ-1 was presented in the epithelial and stromal components of prostate tissue with a higher concentration in the stroma. The TGFβ-1 stromal expression was increased in cases of benign hyperplastic changes in comparison to prostate carcinoma (p < 0.05). On the contrary, the epithelial expression of TGFβ-1 did not show any significant differences between the two cases. On the other hand, IL-6 expression was localized in the epithelial component, with higher levels observed in prostate cancer in comparison to hyperplasia. There was no substantial correlation found between the Gleason score and IL-6 expression. According to our results, the immunohistochemical detection of both TGFβ-1 and IL-6 exhibited variations between benign and malignant samples.
{"title":"Immunohistochemical Expression of Interleukin-6 and Transforming Growth Factor Beta-1 on Prostatic Lesions.","authors":"Alaa Abdulqader Abdulrazaq, Duraid Taha Abdulkareem","doi":"10.1007/s13193-025-02276-x","DOIUrl":"https://doi.org/10.1007/s13193-025-02276-x","url":null,"abstract":"<p><p>Benign prostatic hyperplasia (BPH) and prostatic cancer both represent prostate lesions affecting males. These conditions occur due to the presence of inflammation within the prostate gland. This inflammatory process causes tissue injury and cellular modifications, which are primarily through the cytokine synthesis and secretion. Distinctly, IL-6 (interleukin 6) emerges as a vital part in prostate disease, exerting a profound influence on its development. In addition, the anti-inflammatory cytokines' inclusion, such as tumor necrosis factor beta-1 (TGFβ-1), is evident in the development of both benign prostatic hyperplasia and prostatic cancer. In recent discoveries, researchers are more focused on complex interaction between IL-6 and TGFβ-1 in the prostate pathophysiology. The article aims to assess the IL-6 and TGFβ-1 immunohistochemical expression in prostatic benign and malignant lesions. Formalin-fixed samples that were encapsulated in paraffin were utilized in this work. They were collected from the department of histopathology et al.-Ramadi-Teaching Hospital from patients who were diagnosed with hyperplasia and carcinoma of the prostate. To detect the expression of TGFβ-1 and IL-6, immunohistochemical analysis was performed on the tissue sections. The intensity of stromal staining was determined to assess the stromal expression. Concerning prostate cancer, the relationship between cytokine expression and the Gleason index score was discussed in this work. The results confirm that the TGFβ-1 was presented in the epithelial and stromal components of prostate tissue with a higher concentration in the stroma. The TGFβ-1 stromal expression was increased in cases of benign hyperplastic changes in comparison to prostate carcinoma (<i>p</i> < 0.05). On the contrary, the epithelial expression of TGFβ-1 did not show any significant differences between the two cases. On the other hand, IL-6 expression was localized in the epithelial component, with higher levels observed in prostate cancer in comparison to hyperplasia. There was no substantial correlation found between the Gleason score and IL-6 expression. According to our results, the immunohistochemical detection of both TGFβ-1 and IL-6 exhibited variations between benign and malignant samples.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1632-1638"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708493/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bayesian network (BN) models are graphical structures called the directed acyclic graphs, which model the probabilistic dependencies between variables. In the context of predictive modeling, BN models can intuitively represent the collective contribution of factors in predicting an outcome variable. This study is aimed at developing a BN model in predicting the two-year mortality of patients diagnosed with squamous cell carcinoma of oral cavity (OCSCC). The secondary data for the study was obtained from a published cohort study conducted within the institute after ethical approval. The strength of association of the potential prognostic factors with the outcome variable was determined using multiple logistic regression. The hybrid BN model based on expert opinion and association matrix (BN-H) was developed. The conditional dependencies between the variables were incorporated as the thickness of edges between nodes. Multiple logistic regression (MLR) and BN models based on tree augmented (TAN), expectation maximization (EM), and gradient boosting (GB) method was developed for comparison. Gini coefficient, sensitivity, specificity, misclassification rate, and area under the ROC curve were estimated in both training and testing data for comparison. Age, smoking, alcohol, stage of the cancer, and treatment modality were found be significant prognostic factors for mortality. The association matrix determined that there were significant inter-dependencies between variables. The BN-H model was found to have a comparable predictive accuracy to the MLR model. Bayesian network model developed with expert opinion and appropriate association matrix can be an alternative to existing predictive models for binary outcome.
Supplementary information: The online version contains supplementary material available at 10.1007/s13193-024-02164-w.
{"title":"Utility of Bayesian Network Model for Prediction of Binary Outcome: An Exploratory Study of Mortality Prediction Amongst Squamous Cell Carcinomas of Oral Cavity.","authors":"Sachit Ganapathy, N Sreekumaran Nair, Harichandrakumar Kt, Prasanth Penumadu, Kadhiravan Tamilarasu","doi":"10.1007/s13193-024-02164-w","DOIUrl":"https://doi.org/10.1007/s13193-024-02164-w","url":null,"abstract":"<p><p>Bayesian network (BN) models are graphical structures called the directed acyclic graphs, which model the probabilistic dependencies between variables. In the context of predictive modeling, BN models can intuitively represent the collective contribution of factors in predicting an outcome variable. This study is aimed at developing a BN model in predicting the two-year mortality of patients diagnosed with squamous cell carcinoma of oral cavity (OCSCC). The secondary data for the study was obtained from a published cohort study conducted within the institute after ethical approval. The strength of association of the potential prognostic factors with the outcome variable was determined using multiple logistic regression. The hybrid BN model based on expert opinion and association matrix (BN-H) was developed. The conditional dependencies between the variables were incorporated as the thickness of edges between nodes. Multiple logistic regression (MLR) and BN models based on tree augmented (TAN), expectation maximization (EM), and gradient boosting (GB) method was developed for comparison. Gini coefficient, sensitivity, specificity, misclassification rate, and area under the ROC curve were estimated in both training and testing data for comparison. Age, smoking, alcohol, stage of the cancer, and treatment modality were found be significant prognostic factors for mortality. The association matrix determined that there were significant inter-dependencies between variables. The BN-H model was found to have a comparable predictive accuracy to the MLR model. Bayesian network model developed with expert opinion and appropriate association matrix can be an alternative to existing predictive models for binary outcome.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13193-024-02164-w.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1696-1704"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708483/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-02-24DOI: 10.1007/s13193-025-02228-5
Carlo Ronsini, Irene Iavarone, Maria Giovanna Vastarella, Luigi Della Corte, Giada Andreoli, Giuseppe Bifulco, Luigi Cobellis, Pasquale de Franciscis
The objective of the study is to explore the correlation between inflammation indices (NLR, MLR, PLR) and prognostic factors (myometrial infiltration, LVSI, grading) in FIGO 2023 stage I endometrial carcinoma. From August 2023 to March 2024, a prospective study was conducted on 163 women diagnosed with stage I endometrial cancer. The research methods were established a priori and authorized through evaluation by the Ethics Committee of the individual centers (IRB 30661/2022 of 31/03/2022). The study was then registered on the clinicaltrials.gov platform under NCT05657483. Blood samples were collected preoperatively to measure the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR). Histopathological data on myometrial infiltration, LVSI, and grading were also analyzed. NLR values were 2.07, 2.35, and 2.68 for no infiltration, < 50%, and ≥ 50% myometrial infiltration, respectively (p = 0.033). MLR values were 0.20, 0.23, and 0.26 for the same categories (p = 0.029). PLR values were 119, 140, and 146 (p = 0.043). For LVSI, NLR was 2.17 in negative and 3.23 in diffuse (p = 0.010), while MLR showed 0.20 vs 0.24 (p = 0.054), and PLR showed 125 vs 141 (p = 0.033). Multivariate analysis indicated myometrial infiltration had the strongest correlation with inflammation indices (beta 0.07, CI 95% 0.01-0.13, p = 0.041). Inflammation indices (NLR, MLR, PLR) significantly correlate with myometrial infiltration, LVSI positivity, and higher grading in early-stage endometrial carcinoma, with myometrial infiltration showing the strongest association. These findings suggest that inflammation indices could aid in the prognostic evaluation of endometrial carcinoma. Further research is needed to understand the prognostic implications fully.
本研究旨在探讨FIGO 2023期I期子宫内膜癌炎症指标(NLR、MLR、PLR)与预后因素(肌层浸润、LVSI、分级)的相关性。从2023年8月到2024年3月,对163名诊断为I期子宫内膜癌的女性进行了一项前瞻性研究。研究方法是先验建立的,并通过各中心伦理委员会的评估授权(IRB 30661/2022年3月31日)。该研究随后在clinicaltrials.gov平台注册,编号为NCT05657483。术前采集血液,测定中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)、血小板与淋巴细胞比值(PLR)。我们还分析了肌层浸润、LVSI和分级的组织病理学数据。无浸润的NLR分别为2.07、2.35、2.68,p = 0.033)。同一类别的MLR值分别为0.20、0.23和0.26 (p = 0.029)。PLR值分别为119、140和146 (p = 0.043)。LVSI阴性NLR为2.17,弥漫NLR为3.23 (p = 0.010), MLR为0.20 vs 0.24 (p = 0.054), PLR为125 vs 141 (p = 0.033)。多因素分析显示,肌层浸润与炎症指标相关性最强(β - 0.07, CI 95% 0.01 ~ 0.13, p = 0.041)。早期子宫内膜癌炎症指标(NLR、MLR、PLR)与子宫内膜浸润、LVSI阳性、分级高相关,其中以子宫内膜浸润相关性最强。这些结果提示炎症指标可以帮助评价子宫内膜癌的预后。需要进一步的研究来充分了解其预后意义。
{"title":"Additional Risk Factors Lead to a Measurable Inflammatory Response in Stage I Endometrial Cancer-A Prospective Multicentric Observational Study.","authors":"Carlo Ronsini, Irene Iavarone, Maria Giovanna Vastarella, Luigi Della Corte, Giada Andreoli, Giuseppe Bifulco, Luigi Cobellis, Pasquale de Franciscis","doi":"10.1007/s13193-025-02228-5","DOIUrl":"10.1007/s13193-025-02228-5","url":null,"abstract":"<p><p>The objective of the study is to explore the correlation between inflammation indices (NLR, MLR, PLR) and prognostic factors (myometrial infiltration, LVSI, grading) in FIGO 2023 stage I endometrial carcinoma. From August 2023 to March 2024, a prospective study was conducted on 163 women diagnosed with stage I endometrial cancer. The research methods were established a priori and authorized through evaluation by the Ethics Committee of the individual centers (IRB 30661/2022 of 31/03/2022). The study was then registered on the clinicaltrials.gov platform under NCT05657483. Blood samples were collected preoperatively to measure the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR). Histopathological data on myometrial infiltration, LVSI, and grading were also analyzed. NLR values were 2.07, 2.35, and 2.68 for no infiltration, < 50%, and ≥ 50% myometrial infiltration, respectively (<i>p</i> = 0.033). MLR values were 0.20, 0.23, and 0.26 for the same categories (<i>p</i> = 0.029). PLR values were 119, 140, and 146 (<i>p</i> = 0.043). For LVSI, NLR was 2.17 in negative and 3.23 in diffuse (<i>p</i> = 0.010), while MLR showed 0.20 vs 0.24 (<i>p</i> = 0.054), and PLR showed 125 vs 141 (<i>p</i> = 0.033). Multivariate analysis indicated myometrial infiltration had the strongest correlation with inflammation indices (beta 0.07, CI 95% 0.01-0.13, <i>p</i> = 0.041). Inflammation indices (NLR, MLR, PLR) significantly correlate with myometrial infiltration, LVSI positivity, and higher grading in early-stage endometrial carcinoma, with myometrial infiltration showing the strongest association. These findings suggest that inflammation indices could aid in the prognostic evaluation of endometrial carcinoma. Further research is needed to understand the prognostic implications fully.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1474-1481"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708463/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Adenoid cystic carcinoma, predominantly a tumour of salivary gland, very rarely affects the breast. Very few cases have been reported in literature and there is no optimal consensus on management. In this narrative review, we report a case of adenoid cystic carcinoma breast treated with surgery followed by adjuvant chemotherapy and radiation therapy. It is an indolent tumour with very low predilection for lymphatic dissemination. A balanced translocation in MYB-NFIB fusion gene appears to be fundamental in the pathogenesis. Surgery forms the mainstay treatment option followed by adjuvant radiation in high risk cases, as extrapolated from studies in salivary gland tumour.
{"title":"Adenoid Cystic Carcinoma of Breast-A Narrative Review.","authors":"Subbiah Shanmugam, Archana Elangovan, Bricilla Gnana Preethe, Partheeban Balasundaram, Archana Elangovan","doi":"10.1007/s13193-025-02281-0","DOIUrl":"https://doi.org/10.1007/s13193-025-02281-0","url":null,"abstract":"<p><p>Adenoid cystic carcinoma, predominantly a tumour of salivary gland, very rarely affects the breast. Very few cases have been reported in literature and there is no optimal consensus on management. In this narrative review, we report a case of adenoid cystic carcinoma breast treated with surgery followed by adjuvant chemotherapy and radiation therapy. It is an indolent tumour with very low predilection for lymphatic dissemination. A balanced translocation in MYB-NFIB fusion gene appears to be fundamental in the pathogenesis. Surgery forms the mainstay treatment option followed by adjuvant radiation in high risk cases, as extrapolated from studies in salivary gland tumour.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1745-1747"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145782320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aim: To find the association between cholecystectomy and colorectal cancer.
Methodology: This is a case control study which consisted of 138 cases and 140 controls. This study was conducted with the ethical approval of the ethics committee and has also received the ICMR STS grant. Data of 138 patients who were diagnosed with colorectal cancer in the last 5 years were analyzed for a history of cholecystectomy. Those who developed colorectal cancer within a year of their cholecystectomy were excluded from the study to minimize protopathic bias. The control group was composed of healthy individuals. Data extracted was organized in Microsoft Excel and was analyzed about the main objective. Chi-square test was used to find the association between cholecystectomy and colorectal cancer.
Results: The percentage of cholecystectomy in the colorectal cancer group was 6.5% vs 2.1% in the control group (P value = 0.072). There were no statistically significant associations between diabetes, hypertension, CKD, alcohol intake or smoking, and the incidence of colorectal cancer.
Conclusion: Based on our study, there is no evidence to support an association between colorectal cancer and cholecystectomy.
{"title":"Association Between Cholecystectomy and Colorectal Cancer.","authors":"Adithya Sathya Narayana, Sreekar Agumbe Pai, Advaith N Rao, Anisha Dhavaleshwar","doi":"10.1007/s13193-025-02255-2","DOIUrl":"https://doi.org/10.1007/s13193-025-02255-2","url":null,"abstract":"<p><strong>Aim: </strong>To find the association between cholecystectomy and colorectal cancer.</p><p><strong>Methodology: </strong>This is a case control study which consisted of 138 cases and 140 controls. This study was conducted with the ethical approval of the ethics committee and has also received the ICMR STS grant. Data of 138 patients who were diagnosed with colorectal cancer in the last 5 years were analyzed for a history of cholecystectomy. Those who developed colorectal cancer within a year of their cholecystectomy were excluded from the study to minimize protopathic bias. The control group was composed of healthy individuals. Data extracted was organized in Microsoft Excel and was analyzed about the main objective. Chi-square test was used to find the association between cholecystectomy and colorectal cancer.</p><p><strong>Results: </strong>The percentage of cholecystectomy in the colorectal cancer group was 6.5% vs 2.1% in the control group (<i>P</i> value = 0.072). There were no statistically significant associations between diabetes, hypertension, CKD, alcohol intake or smoking, and the incidence of colorectal cancer.</p><p><strong>Conclusion: </strong>Based on our study, there is no evidence to support an association between colorectal cancer and cholecystectomy.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1504-1507"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145782781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-02-27DOI: 10.1007/s13193-025-02251-6
Cherry Bansal, Gurupriya Anand, Anshika Goyal
Gleason grading system was first introduced in the 1960s by Dr. Donald Gleason and has since been used worldwide for the grading of prostate cancer. Over the years it has undergone several modifications but has still retained its status as the most popular scoring system for prostate. Using a systematic literature review, we aim to highlight the changes the Gleason scoring has undergone, their strengths and limitations as well the future directives. Gleason scoring underwent major changes from its original conception in the International Society of Urologic Pathology (ISUP) consensus meetings held in 2005, 2014 and 2019. The latest change in Gleason scoring makes it possible to report the scoring, help alleviate patient anxiety and has shown good reproducibility and less inter-user variability. Gleason scoring system is a popular tool among pathologists and clinicians alike owing to its flexibility, utility and dependability. With advancements in the medical field and the use of artificial intelligence, it is expected to undergo further tempering.
{"title":"Evolution of Gleason Score Prostate - A Review.","authors":"Cherry Bansal, Gurupriya Anand, Anshika Goyal","doi":"10.1007/s13193-025-02251-6","DOIUrl":"https://doi.org/10.1007/s13193-025-02251-6","url":null,"abstract":"<p><p>Gleason grading system was first introduced in the 1960s by Dr. Donald Gleason and has since been used worldwide for the grading of prostate cancer. Over the years it has undergone several modifications but has still retained its status as the most popular scoring system for prostate. Using a systematic literature review, we aim to highlight the changes the Gleason scoring has undergone, their strengths and limitations as well the future directives. Gleason scoring underwent major changes from its original conception in the International Society of Urologic Pathology (ISUP) consensus meetings held in 2005, 2014 and 2019. The latest change in Gleason scoring makes it possible to report the scoring, help alleviate patient anxiety and has shown good reproducibility and less inter-user variability. Gleason scoring system is a popular tool among pathologists and clinicians alike owing to its flexibility, utility and dependability. With advancements in the medical field and the use of artificial intelligence, it is expected to undergo further tempering.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1538-1545"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-03-04DOI: 10.1007/s13193-025-02266-z
Elizabeth M Iype, Shirish Patil, Japneet Kaur, Sreekumar A, Preethi S George, Nebu Abraham George, Bipin Thomas Varghese, Shaji Thomas
Papillary thyroid carcinoma and follicular thyroid carcinoma both are collectively referred as well-differentiated thyroid carcinomas (WDTC). Both carcinoma types carry an excellent prognosis except in cases with aggressive backgrounds or clinicopathological features. We herein investigated survival rates and various prognostic factors in patients with WDTC. In this retrospective study, a total of 602 patients diagnosed as having WDTC, who had undergone total thyroidectomy with or without neck dissection and had received adequate radioactive iodine treatment from January, 2006, to December, 2008 were included. Data were collected by medical record review. Size of the tumor (p < 0.001) and extrathyroidal extension (p < 0.001) were factors for developing regional lymph node metastasis. Nodal metastasis N0 (central compartment) and N1 (lateral compartment) did not adversely affect 7-year overall survival (p < 0.8). For both regional metastasis (p = 0.001) and distant metastasis (p = 0.025), age > 55 years adversely affected overall survival. No significant difference was found in 7-year overall survival between patients with gross and microscopic extrathyroidal extension (77.6% vs. 74.5%, p = 0.18), 10-year overall survival with gross and microscopic extrathyroidal extension was also non-significant (71.1% vs. 81.3%, p = 0.509). There was no role of prophylactic central compartment neck dissection in treating patients with WDTC. Overall survival at 3, 5, 7 years, and 10 years were 94.2%, 88.8%, 85.2%, and 82.7%, respectively. It can be concluded that the survival was adversely influenced by advanced age (> 55 years). Moreover, poor long-term overall survival and disease-free survival were observed in our study population owing to advanced stage carcinoma (extrathyroidal extension and lymph node metastasis) at presentation.
{"title":"A Study of Survival Outcomes in Well-Differentiated Thyroid Carcinomas at a Tertiary Health Center in South India.","authors":"Elizabeth M Iype, Shirish Patil, Japneet Kaur, Sreekumar A, Preethi S George, Nebu Abraham George, Bipin Thomas Varghese, Shaji Thomas","doi":"10.1007/s13193-025-02266-z","DOIUrl":"https://doi.org/10.1007/s13193-025-02266-z","url":null,"abstract":"<p><p>Papillary thyroid carcinoma and follicular thyroid carcinoma both are collectively referred as well-differentiated thyroid carcinomas (WDTC). Both carcinoma types carry an excellent prognosis except in cases with aggressive backgrounds or clinicopathological features. We herein investigated survival rates and various prognostic factors in patients with WDTC. In this retrospective study, a total of 602 patients diagnosed as having WDTC, who had undergone total thyroidectomy with or without neck dissection and had received adequate radioactive iodine treatment from January, 2006, to December, 2008 were included. Data were collected by medical record review. Size of the tumor (<i>p</i> < 0.001) and extrathyroidal extension (<i>p</i> < 0.001) were factors for developing regional lymph node metastasis. Nodal metastasis N0 (central compartment) and N1 (lateral compartment) did not adversely affect 7-year overall survival (<i>p</i> < 0.8). For both regional metastasis (<i>p</i> = 0.001) and distant metastasis (<i>p</i> = 0.025), age > 55 years adversely affected overall survival. No significant difference was found in 7-year overall survival between patients with gross and microscopic extrathyroidal extension (77.6% vs. 74.5%, <i>p</i> = 0.18), 10-year overall survival with gross and microscopic extrathyroidal extension was also non-significant (71.1% vs. 81.3%, <i>p</i> = 0.509). There was no role of prophylactic central compartment neck dissection in treating patients with WDTC. Overall survival at 3, 5, 7 years, and 10 years were 94.2%, 88.8%, 85.2%, and 82.7%, respectively. It can be concluded that the survival was adversely influenced by advanced age (> 55 years). Moreover, poor long-term overall survival and disease-free survival were observed in our study population owing to advanced stage carcinoma (extrathyroidal extension and lymph node metastasis) at presentation.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1574-1581"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708494/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Treatment for colorectal cancer has improved significantly over the last few decades. The feasibility of treating colorectal cancer recurrence is also increasing. The surveillance protocol applied influences the pattern of diagnosis of recurrence. Adherence to intense follow up protocols may be challenged by limitation of resource, pointing to the scope of forming tailored strategies. The objectives were to determine the rate of salvage, disease-free and overall survival, the types of local therapy applied, morbidity associated with radical local treatment, and the factors influencing survival of patients followed up using a low intensity regimen after curative treatment for recurrent colorectal cancer. We included patients diagnosed with colorectal cancer recurrence from January 2010 to December 2016 at the institute. The clinicopathological and treatment details were collected. Treatment outcomes were analyzed and compared with the baseline characteristics. Of 109 recurrences, 26 (23.8%) were offered curative therapy. Locoregional treatment modalities consisted of four cases of pelvic exenteration (18.2%), four (18.2%) resections of peritoneal deposits including two (9.1%) multivisceral resections, four (18.2%) hepatic resections, two (9.1%) lung metastasectomies, one (4.5%) retroperitoneal lymph node dissection, and two (4.5%) ablative procedures. Four (18.2%) and one (4.5%) cases received chemoradiotherapy and systemic therapy alone. Surgical resection had 6.2% Clavien-Dindo grade III, 25% grade II, and 25% grade I morbidities. With a median follow-up of 95 months, the median DFS and OS were 48 months and 55 months for curatively treated patients. The rate of curative therapy was low in a low-intensity follow-up regimen (23.8%). Yet, curative treatment including complex resections offers a survival advantage with acceptable morbidity rates, in select patients with limited disease affecting a single region.
{"title":"Feasibility and Outcomes of Salvage Therapy for Recurrence in Colorectal Cancer Patients Followed Up with a Low-Intensity Regime.","authors":"Prasanth Poolakkil, Nizamuddeen Pareekkutty, Satheesan Balasubramanian, Bindu Anilkumar","doi":"10.1007/s13193-025-02227-6","DOIUrl":"https://doi.org/10.1007/s13193-025-02227-6","url":null,"abstract":"<p><p>Treatment for colorectal cancer has improved significantly over the last few decades. The feasibility of treating colorectal cancer recurrence is also increasing. The surveillance protocol applied influences the pattern of diagnosis of recurrence. Adherence to intense follow up protocols may be challenged by limitation of resource, pointing to the scope of forming tailored strategies. The objectives were to determine the rate of salvage, disease-free and overall survival, the types of local therapy applied, morbidity associated with radical local treatment, and the factors influencing survival of patients followed up using a low intensity regimen after curative treatment for recurrent colorectal cancer. We included patients diagnosed with colorectal cancer recurrence from January 2010 to December 2016 at the institute. The clinicopathological and treatment details were collected. Treatment outcomes were analyzed and compared with the baseline characteristics. Of 109 recurrences, 26 (23.8%) were offered curative therapy. Locoregional treatment modalities consisted of four cases of pelvic exenteration (18.2%), four (18.2%) resections of peritoneal deposits including two (9.1%) multivisceral resections, four (18.2%) hepatic resections, two (9.1%) lung metastasectomies, one (4.5%) retroperitoneal lymph node dissection, and two (4.5%) ablative procedures. Four (18.2%) and one (4.5%) cases received chemoradiotherapy and systemic therapy alone. Surgical resection had 6.2% Clavien-Dindo grade III, 25% grade II, and 25% grade I morbidities. With a median follow-up of 95 months, the median DFS and OS were 48 months and 55 months for curatively treated patients. The rate of curative therapy was low in a low-intensity follow-up regimen (23.8%). Yet, curative treatment including complex resections offers a survival advantage with acceptable morbidity rates, in select patients with limited disease affecting a single region.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1376-1383"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708428/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-02-24DOI: 10.1007/s13193-025-02246-3
Elaheh Gheybi, Fatemeh Molaei, Mohammad Mahdi Forghanifard
Cell signaling pathways are important in different biological processes such as cell survival, proliferation, differentiation, as well as tumorigenesis. The complex interactions between genes and signaling pathways have a role in the progression and development of malignancies. Our aim in this study was to explore the concomitant expression of GLI1 and VENTX genes in esophageal squamous cell carcinoma (ESCC) and evaluate its relevance with clinicopathological features. Levels of GLI1 and VENTX mRNA expression in 50 ESCC patients were compared to the correlated margin normal tissues using relative comparative RT-qPCR. A significant correlation between the mRNA expression of GLI1 and VENTX was observed in ESCC patients (P = 0.003, P ). Expression of GLI1 was significantly increased in samples with high levels of VENTX mRNA expression. Moreover, a significant correlation between VENTX and GLI1 was detected in non-metastatic early tumors (stages I and II). The significant correlation between these genes in non-metastasized early tumors indicates the importance of GLI1 and VENTX concomitant expression as a value for early ESCCs. It may be extrapolated that VENTX through the BMP pathway activates the expression of GLI1 followed by aggressive phenotype in ESCC.
细胞信号通路在细胞存活、增殖、分化以及肿瘤发生等不同的生物学过程中起着重要的作用。基因和信号通路之间复杂的相互作用在恶性肿瘤的进展和发展中起着重要作用。本研究的目的是探讨GLI1和VENTX基因在食管鳞状细胞癌(ESCC)中的共同表达,并评估其与临床病理特征的相关性。采用相对比较RT-qPCR将50例ESCC患者的GLI1和VENTX mRNA表达水平与相关边缘正常组织进行比较。在ESCC患者中GLI1和VENTX mRNA的表达有显著相关性(P = 0.003, P 0.05)。在VENTX mRNA高表达的样品中,GLI1的表达显著增加。此外,在非转移性早期肿瘤(I期和II期)中检测到VENTX和GLI1之间的显著相关性。这些基因在非转移性早期肿瘤中的显著相关性表明GLI1和VENTX同时表达对于早期escc具有重要价值。可以推断,通过BMP通路的VENTX激活了ESCC中GLI1的表达,随后出现了侵袭性表型。
{"title":"GLI1-VENTX Expression Pattern as a Prognostic Value for Non-Metastatic Early Esophageal Squamous Cell Carcinoma.","authors":"Elaheh Gheybi, Fatemeh Molaei, Mohammad Mahdi Forghanifard","doi":"10.1007/s13193-025-02246-3","DOIUrl":"https://doi.org/10.1007/s13193-025-02246-3","url":null,"abstract":"<p><p>Cell signaling pathways are important in different biological processes such as cell survival, proliferation, differentiation, as well as tumorigenesis. The complex interactions between genes and signaling pathways have a role in the progression and development of malignancies. Our aim in this study was to explore the concomitant expression of GLI1 and VENTX genes in esophageal squamous cell carcinoma (ESCC) and evaluate its relevance with clinicopathological features. Levels of GLI1 and VENTX mRNA expression in 50 ESCC patients were compared to the correlated margin normal tissues using relative comparative RT-qPCR. A significant correlation between the mRNA expression of GLI1 and VENTX was observed in ESCC patients (<i>P</i> = 0.003, <i>P</i> <math><mrow><mo><</mo> <mn>0.05</mn></mrow> </math> ). Expression of GLI1 was significantly increased in samples with high levels of VENTX mRNA expression. Moreover, a significant correlation between VENTX and GLI1 was detected in non-metastatic early tumors (stages I and II). The significant correlation between these genes in non-metastasized early tumors indicates the importance of GLI1 and VENTX concomitant expression as a value for early ESCCs. It may be extrapolated that VENTX through the BMP pathway activates the expression of GLI1 followed by aggressive phenotype in ESCC.</p>","PeriodicalId":46707,"journal":{"name":"Indian Journal of Surgical Oncology","volume":"16 6","pages":"1482-1487"},"PeriodicalIF":0.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12708451/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}